棕榈酸镁 | 2601-98-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 棕榈酸镁
• 中文别名: 十六酸镁盐
• CAS: 2601-98-1
• 化学式: C16H32MgO2
• 分子量: 280.73
• InChiKey: APBJXGVIZPQIIV-UHFFFAOYSA-N

物化性质

• 熔点：
  121 °C
• LogP：
  7.154 (est)

计算性质

• 辛醇/水分配系数(LogP)：
  5.17
• 重原子数：
  19
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.94
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
  申请人：SENOMYX, INC.

  公开号：US20160376263A1

  公开（公告）日：2016-12-29

  The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.

  本发明涵盖已知用于改变苦味感知的化合物和组合物，以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种：冷却剂；无活性药物成分；活性药用成分；食品添加剂或食品；调味剂或调味增强剂；食品或饮料产品；苦味化合物；甜味剂；苦味剂；酸味调味剂；咸味调味剂；鲜味调味剂；植物或动物产品；已知用于宠物护理产品中的化合物；已知用于个人护理产品中的化合物；已知用于家用产品中的化合物；制药制剂；局部制剂；大麻衍生或与大麻相关的产品；已知用于口腔护理产品中的化合物；饮料；香味、香水或除臭剂；已知用于消费品中的化合物；硅化合物；磨料；表面活性剂；发热剂；吸烟物品；脂肪、油脂或乳化剂；和/或益生菌或补充剂。
• Pharmaceutical composition comprising a salt of rosigliatazone
  申请人：KRKA, tovarna zdravil, d.d., Novo mesto

  公开号：EP1967182A1

  公开（公告）日：2008-09-10

  The present invention relates to a pharmaceutical composition comprising (a) 0.1 - 10 % by weight of a salt of rosiglitazone as active ingredient, and (b) 0.2 - 4.0 % by weight of disintegrant and a process for producing the same.

  这项发明涉及一种制药组合物，包括 (a) 0.1 - 10%重量的罗格列酮盐作为活性成分，以及 (b) 0.2 - 4.0%重量的崩解剂 以及生产该组合物的方法。
• [EN] PRODRUG COMPOSITIONS AND METHODS OF TREATMENT<br/>[FR] COMPOSITIONS DE PROMÉDICAMENT ET PROCÉDÉS DE TRAITEMENT
  申请人：AQUESTIVE THERAPEUTICS INC

  公开号：WO2021087359A1

  公开（公告）日：2021-05-06

  Pharmaceutical compositions include a prodrug of epinephrine are described.

  药物组合物包括表述的肾上腺素前药。
• Detergent cosmetic compositions containing an anionic surfactant derived from amino acids and salts thereof and an insoluble conditioning agent and uses thereof
  申请人：L'OREAL

  公开号：US20020183217A1

  公开（公告）日：2002-12-05

  Novel detergent cosmetic compositions comprising, in a cosmetically acceptable medium, (a) at least one anionic surfactant chosen from the N-acylated compounds of mono- and polyamidated polycarboxylic amino acids and the salts of said acids and (b) at least one insoluble conditioning agent. This combination imparts at least one of the cosmetic properties of sleekness, lightness and softness while minimizing keratinous fiber regreasing phenomenon. These compositions are used, for example, for washing and/or conditioning a keratinous material such as the hair and the skin.

  含有新型洗涤剂的化妆品组合物，包括在一种适合化妆的介质中，(a) 至少一种阴离子表面活性剂，选择自单和多酰化聚羧基氨基酸的N-酰化化合物和该酸的盐，以及(b) 至少一种不溶性调理剂。这种组合物赋予了至少一种化妆特性，如光滑、轻盈和柔软，同时最大程度地减少角质纤维再油化现象。这些组合物例如用于洗涤和/或调理角质材料，如头发和皮肤。
• [EN] PROCESS FOR IMPROVED OPIOID SYNTHESIS<br/>[FR] PROCÉDÉ POUR AMÉLIORER LA SYNTHÈSE D'OPIOÏDES
  申请人：RHODES TECHNOLOGIES

  公开号：WO2014013311A1

  公开（公告）日：2014-01-23

  Compounds and compositions for use as starting materials or intermediate materials in the preparation of opioids including, e.g., oxycodone base and/or an oxycodone salt; processes for preparing these compounds and compositions; uses of these compounds and compositions in the preparation of APIs and pharmaceutical dosage forms; and uses of said APIs and pharmaceutical dosage forms in the treatment of medical conditions.

  用于制备阿片类药物的起始物或中间物的化合物和组合物，例如，羟考酮基和/或羟考酮盐；制备这些化合物和组合物的过程；这些化合物和组合物在制备活性药物成分和制药剂量形式中的用途；以及这些活性药物成分和制药剂量形式在治疗医疗状况中的用途。